Matej Bendzala1, Peter Sabaka1, Martin Caprnda1, Andrea Komornikova1, Maria Bisahova1, Ruth Baneszova1, Daniel Petrovic2,3, Robert Prosecky4, Luis Rodrigo5, Peter Kruzliak6,7, Andrej Dukat1. 1. 1st Department of Internal Medicine, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia. 2. Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. 3. University Medical Centre Ljubljana, Ljubljana, Slovenia. 4. Department of Internal Medicine, Brothers of Mercy Hospital, Brno, Czech Republic. 5. Faculty of Medicine, University of Oviedo, Central University Hospital of Asturias (HUCA), Oviedo, Spain. 6. Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho tr. 1/1946, 612 42, Brno, Czech Republic. kruzliakpeter@gmail.com. 7. 2nd Department of Surgery, Center for Vascular Disease, St. Anne's University Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic. kruzliakpeter@gmail.com.
Abstract
BACKGROUND: The blood concentrations of total cholesterol and low-density lipoprotein (LDL) do not predict survival in patients older than 60 years. The atherogenic index of plasma (AIP) is a logarithm of the triacylglycerol to high-density lipoprotein (HDL) ratio and a surrogate for the concentration of small dense LDL. It might be a better reflection of the risk of all-cause death in elderly patients. METHODS: We conducted a prospective observational study of patients with arterial hypertension older than 60 years. The concentrations of total cholesterol, LDL, HDL and triacylglycerol were measured at the time of the recruitment and the patients were observed for 10 years. Cox regression analysis was performed to assess the effects of lipoproteins and AIP on survival. RESULTS: A total of 500 patients were recruited and 473 of them (226 men, 247 women) either died or successfully completed the 10-year follow-up and were included in the analysis. The AIP was positively associated, while HDL concentration was negatively associated with the risk of all-cause death adjusted for age, smoking habits, statin use, history of diabetes mellitus, myocardial infarction, stroke and peripheral artery occlusive disease (PAOD) in elderly women but not in men. The LDL, total cholesterol, triacylglycerol and non-HDL concentrations were not associated with the risk of death in both sexes. CONCLUSIONS: The AIP is positively associated with the risk of all-cause death in elderly women with arterial hypertension independent of age, smoking habits, statin therapy and comorbidities.
BACKGROUND: The blood concentrations of total cholesterol and low-density lipoprotein (LDL) do not predict survival in patients older than 60 years. The atherogenic index of plasma (AIP) is a logarithm of the triacylglycerol to high-density lipoprotein (HDL) ratio and a surrogate for the concentration of small dense LDL. It might be a better reflection of the risk of all-cause death in elderly patients. METHODS: We conducted a prospective observational study of patients with arterial hypertension older than 60 years. The concentrations of total cholesterol, LDL, HDL and triacylglycerol were measured at the time of the recruitment and the patients were observed for 10 years. Cox regression analysis was performed to assess the effects of lipoproteins and AIP on survival. RESULTS: A total of 500 patients were recruited and 473 of them (226 men, 247 women) either died or successfully completed the 10-year follow-up and were included in the analysis. The AIP was positively associated, while HDL concentration was negatively associated with the risk of all-cause death adjusted for age, smoking habits, statin use, history of diabetes mellitus, myocardial infarction, stroke and peripheral artery occlusive disease (PAOD) in elderly women but not in men. The LDL, total cholesterol, triacylglycerol and non-HDL concentrations were not associated with the risk of death in both sexes. CONCLUSIONS: The AIP is positively associated with the risk of all-cause death in elderly women with arterial hypertension independent of age, smoking habits, statin therapy and comorbidities.
Entities:
Keywords:
Atherogenic index; Elderly population; HDL; LDL; Risk of mortality
Authors: G Zuliani; M Cavalieri; M Galvani; S Volpato; A Cherubini; S Bandinelli; A M Corsi; F Lauretani; J M Guralnik; R Fellin; L Ferrucci Journal: J Gerontol A Biol Sci Med Sci Date: 2010-03-18 Impact factor: 6.053
Authors: Donald Lloyd-Jones; Robert Adams; Mercedes Carnethon; Giovanni De Simone; T Bruce Ferguson; Katherine Flegal; Earl Ford; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary McDermott; James Meigs; Dariush Mozaffarian; Graham Nichol; Christopher O'Donnell; Veronique Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan Wong; Judith Wylie-Rosett; Yuling Hong Journal: Circulation Date: 2008-12-15 Impact factor: 29.690
Authors: Annelies W E Weverling-Rijnsburger; Iris J A M Jonkers; Eric van Exel; Jacobijn Gussekloo; Rudi G J Westendorp Journal: Arch Intern Med Date: 2003-07-14
Authors: J David Curb; Robert D Abbott; Beatriz L Rodriguez; Kamal H Masaki; Randi Chen; Jordan S Popper; Helen Petrovitch; G Webster Ross; Irwin J Schatz; Gina C Belleau; Katsuhiko Yano Journal: Am J Epidemiol Date: 2004-07-15 Impact factor: 4.897
Authors: Anne P Toft-Petersen; Hans H Tilsted; Jens Aarøe; Klaus Rasmussen; Thorkil Christensen; Bruce A Griffin; Inge V Aardestrup; Annette Andreasen; Erik B Schmidt Journal: Lipids Health Dis Date: 2011-01-25 Impact factor: 3.876
Authors: Ashuin Kammar-García; Patricia López-Moreno; María Elena Hernández-Hernández; Angélica María Ortíz-Bueno; María de Lurdez Consuelo Martínez-Montaño Journal: Proc (Bayl Univ Med Cent) Date: 2020-08-21